Clinical Evaluation of PET-CT for Staging of Colorectal Lung Metastases

Clinical Evaluation of PET-CT for Staging of Colorectal Lung Metastases - a Prospective Monocentric Feasibility Study

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02942901

Enrollment

Registered

2016-10-24

Start date

2015-01-31

Completion date

2020-01-01

Last updated

2020-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metastatic Colorectal Cancer

Keywords

PET-CT, pulmonary metstasectomy

Brief summary

Surgery has been available for the treatment of pulmonary metastases in metastatic colorectal cancer and promising overall survival was observed in retrospective studies with selected patients. This study investigated whether the preoperative FDG- PET/CT scan influences survival in this patient group. Furthermore, we tried to identify other prognostic factors associated with overall survival and progression-free survival.

Interventions

PROCEDUREPET-CT

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients over 18 years with pulmonary metastases eligible for pulmonary metastasectomy

Exclusion criteria

* Second primary cancer within the last 2 years (exception basal cell carcinoma of the skin) * Pregnancy, * Drug addiction, * Renal dialysis

Design outcomes

Primary

Measure	Time frame
Overall Survival	5 years

Secondary

Measure	Time frame
Number and sites of metastases detected by PET-CT	3 years

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026